Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 772 | 2,902 | 303 | 303 | 303 |
| Gross Profit | 772 | 2,902 | 303 | 303 | 303 |
| Operating Expenses | 3,952 | 5,813 | 7,640 | 8,141 | 18,098 |
| Operating Income | -3,180 | -2,911 | -7,336 | -7,838 | -17,795 |
| Interest Expense | 718 | 2,147 | 1,746 | 1,244 | 489 |
| Other Income | -1,174 | -818 | 3,751 | 1,036 | -810 |
| Pre-tax Income | -5,071 | -5,876 | -5,331 | -8,046 | -19,095 |
| Income Tax | -3,151 | 498 | N/A | N/A | 4 |
| Net Income Continuous | -1,921 | -6,373 | -5,331 | -8,046 | -19,099 |
| Net Income | $-1,921 | $-6,373 | $-5,331 | $-8,046 | $-19,099 |
| EPS Basic Total Ops | -113.60 | -46.40 | -35.20 | -54.40 | -131.20 |
| EPS Basic Continuous Ops | -12.29 | -37.86 | -34.90 | -54.26 | -131.73 |
| EPS Diluted Total Ops | -113.60 | -60.80 | -35.20 | -60.80 | -131.20 |
| EPS Diluted Continuous Ops | -12.29 | -37.82 | -34.90 | -54.09 | -131.73 |
| EBITDA(a) | $-2,503 | $-2,241 | $-6,664 | $-7,158 | $-17,126 |